← Back to Search

Mobile Technology for HIV Prevention (YouthHealth Trial)

N/A
Waitlist Available
Research Sponsored by New York State Psychiatric Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
People who do not have the cognitive capacity to consent determined by the researcher conducting the consent process
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month
Awards & highlights
No Placebo-Only Group

Summary

This trial will help us to understand how the mobile phone-based intervention affects HIV incidence, mental health, and alcohol use outcomes.

Who is the study for?
This trial is for adolescents aged 15-19 living in the greater Masaka region of southern Uganda who own a mobile phone and can consent to participate. They should not have taken part in Phase I of the study, ensuring new participants for Phase II.
What is being tested?
The study tests an adapted text-message and interactive voice response (IVR) system aimed at preventing HIV and addressing sexual, mental health, and alcohol use issues among youth. Participants will be randomly assigned to receive this mobile intervention or standard care.
What are the potential side effects?
Since this trial involves information dissemination via mobile technology rather than medical interventions, traditional side effects are not applicable. However, there may be risks related to privacy concerns or potential distress from sensitive content.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am able to understand and agree to participate in the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HIV-AIDS Test
Secondary study objectives
Alcohol Use
Anxiety
Depression
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants in this arm will receive the mobile phone-based intervention.
Group II: Standard of careActive Control1 Intervention
Participants in this arm will receive only standard of care.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineOTHER
1,991 Previous Clinical Trials
2,295,684 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,917 Previous Clinical Trials
2,738,665 Total Patients Enrolled
New York State Psychiatric InstituteLead Sponsor
478 Previous Clinical Trials
153,773 Total Patients Enrolled

Media Library

Youth Health SMS Clinical Trial Eligibility Overview. Trial Name: NCT05130151 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Intervention, Standard of care
Human Immunodeficiency Virus Infection Clinical Trial 2023: Youth Health SMS Highlights & Side Effects. Trial Name: NCT05130151 — N/A
Youth Health SMS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05130151 — N/A
~12 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top